Cancer drug developed by Introgen founder meets with clinical success
Austin Business Journal 28-May-08
A gene therapy developed at the University of Texas M.D. Anderson Cancer Center and licensed by Introgen Therapeutics Inc. is the first to succeed in a phase III clinical trial in the United States. See complete article.
Nanotechnology Cancer Treatment: A New Tool In Radiation Therapy
Nanovip.com 28-May-08
A nanotech approach to overcoming the resistance of some cancer cells to radiation therapy has been successfully tested in mice. From the National Cancer Institute's Alliance for Nanotechnology in Cancer "Nanoparticle-Induced heating boosts antitumor radiation therapy":
Radiation therapy is a time-honored and effective component of modern cancer therapy, but its ultimate utility is limited by the fact that some cancer cells are resistant to ionizing radiation. Now, a research team led by Sunil Krishnan, M.D., of the University of Texas M.D. Anderson Cancer Center, has found that pretreating tumors with gold nanoparticles and near-infrared radiation dramatically improves the response of tumors to radiation therapy. See complete article.
Report Shows UT System Gains in Diversity, Research, Graduation Rates
16-May-08
Over the last five years, institutions within The University of Texas System have become more diverse in their student bodies, increased their research capacity by more than one-third and raised graduation rates at most academic institutions, according to an annual UT System report that gauges quality, impact, productivity and student outcomes.
...
Also, as competition for research funding increased on a national scale from 2003 to 2007, research expenditures at the UT System rose by 34.1 percent, from $1.5 billion to more than $1.9 billion. In yet another measurement, five UT System institutions posted increases in four-year graduation rates while four posted increases in six-year graduation rates. See complete news release.
UTHSC to create trauma research center
Houston Business Journal - 06-May-08
The University of Texas Health Science Center at Houston has received a $5 million grant from the Texas Emerging Technology Fund to create a trauma research center.
The Center for Transitional Injury Research will be headed by Dr. John Holcomb, a U.S. Army trauma surgeon. The ETF funds will be used to recruit leading scientists and surgeons in trauma care and new medical technologies.
The grant was announced in Houston on Tuesday by Lt. Gov. David Dewhurst.
Besides the ETF grant, an additional $13 million has been committed by UTHSC, Memorial Hermann Hospital System and the University of Texas System Medical Foundation to help establish the new research center. See complete article.
